PRESS RELEASE published on 03/24/2023 at 18:30, 2 years 11 months ago Jaguar Health Announces Time Change for March 27th Investor Webcast to 8:00 AM EDT
PRESS RELEASE published on 03/23/2023 at 13:30, 2 years 11 months ago Leading Cancer Patient Advocate Kelly Shanahan, M.D., Joins Jaguar Health's Scientific Advisory Board
PRESS RELEASE published on 03/21/2023 at 13:30, 2 years 11 months ago Jaguar Health to Hold Investor Webcast Monday, March 27th at 8:30 AM EDT Regarding Q4 2022 Financials & Corporate Updates
PRESS RELEASE published on 03/15/2023 at 13:30, 2 years 11 months ago Jaguar Health Celebrates U.N. International Day of Forests with Milestone of Providing Income to 20,000+ People Living in Tropical Rainforest Communities
PRESS RELEASE published on 03/13/2023 at 13:30, 2 years 11 months ago Jaguar Health Leveraging AI to Support Patient Access to Mytesi, the Company's FDA-Approved Prescription Drug
PRESS RELEASE published on 03/02/2023 at 14:30, 2 years 11 months ago Jaguar Health to Present at BioTrinity 2023 Conference’s R&D Spotlight on Rare Diseases
PRESS RELEASE published on 02/28/2023 at 14:30, 2 years 11 months ago FDA Grants Orphan Drug Designation to Jaguar Health for Crofelemer for Microvillus Inclusion Disease (MVID), a Second Rare Disease Indication in the US
PRESS RELEASE published on 02/23/2023 at 14:30, 3 years ago Jaguar Health Receives Notice of Allowance for U.S. Patent for Lead FDA Approved Drug Crofelemer
PRESS RELEASE published on 02/21/2023 at 14:30, 3 years ago Jaguar Health Achieves Approximately 75% Enrollment in Pivotal Phase 3 OnTarget Trial of Crofelemer for Cancer Therapy-Related Diarrhea
PRESS RELEASE published on 02/09/2023 at 14:30, 3 years ago Jaguar Health Announces Initial Close in Private Placement Financing Round for Napo Therapeutics S.p.A.
Published on 02/28/2026 at 10:00, 1 hour 2 minutes ago Storm Exploration Issues Shares to Eabametoong First Nation
Published on 02/28/2026 at 03:00, 8 hours 2 minutes ago Dynamite Blockchain Announces Change in Auditor
Published on 02/28/2026 at 02:00, 9 hours 2 minutes ago Empress Reports 2025 Year End Financial Results
Published on 02/28/2026 at 00:10, 10 hours 52 minutes ago Algo Grande Copper Closes Oversubscribed $6.52 Million Financing and Strengthens Board at AGM
Published on 02/27/2026 at 17:59, 17 hours 3 minutes ago EQS-Adhoc: 4finance completes sale of TBI Bank to Advent International
Published on 02/27/2026 at 17:33, 17 hours 28 minutes ago 4finance Holding S.A. reports results for the year ending 31 December 2025
Published on 02/27/2026 at 23:00, 12 hours 2 minutes ago Biophytis increases to €2 million the ceiling of its bond facility with Hexagon Capital Fund
Published on 02/27/2026 at 18:02, 16 hours 59 minutes ago AXA: Execution of a share repurchase agreement in relation to AXAs share buy-back program of up to Euro 1.25 billion
Published on 02/27/2026 at 17:45, 17 hours 17 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of December 31, 2025
Published on 02/27/2026 at 17:45, 17 hours 17 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2026
Published on 02/27/2026 at 08:45, 1 day 2 hours ago Air Liquide and Holcim sign an agreement to decarbonize cement production with a carbon capture project in Belgium
